[{"_1":2,"_97":-5,"_98":-5},"loaderData",{"_3":4,"_26":27,"_28":29},"root",{"_5":6,"_7":-5,"_8":9},"locale","en","session","ENV",{"_10":11,"_12":13,"_14":15,"_16":17,"_18":19,"_20":21,"_22":23,"_24":25},"APP_ENV","production","APP_URL","https://veritask.ai","GA_MEASUREMENT_ID","G-X1BV3QBZEM","META_PIXEL_ID","4698743733686194","TIKTOK_PIXEL_IDS","D8A3HTBC77U9J3L243V0","CLARITY_PROJECT_ID","wn9rn7xb4l","MIDTRANS_CLIENT_KEY","Mid-client-hwjEU5pmwAKVMbIA","MIDTRANS_SNAP_URL","https://app.midtrans.com/snap/snap.js","routes/$locale",{"_5":6},"routes/$locale.search-engine.regulation.$regulationId",{"_30":31,"_32":33},"regulationId","a90a8fa7-7842-4331-ab69-0204431c3fa2","regulationData",{"_34":31,"_35":36,"_93":94,"_95":96},"regulation_id","overview",{"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":48,"_49":50,"_51":52,"_58":59,"_60":61,"_65":66,"_70":-5,"_71":-5,"_72":-5,"_73":-5,"_74":-5,"_75":76,"_77":78,"_79":80,"_81":82,"_83":84,"_85":-5,"_86":-5,"_87":-5,"_88":-5,"_89":-5,"_90":-5,"_91":92},"title","Peraturan Badan Pengawas Obat dan Makanan Nomor 7 Tahun 2026 tentang Promosi dan Iklan Obat","short_title","Peraturan Badan Pengawas Obat dan Makanan Nomor 7 Tahun 2026","number","7","year","2026","published_date","2026-04-16","effective_date","2026-04-29","status_id","3611a577-44a0-41ad-986d-7457e14f52ff","status",{"_53":50,"_54":55,"_56":57},"id","name","Berlaku","description","Peraturan yang masih berlaku dan memiliki kekuatan hukum yang mengikat","type_id","6f5779f5-e2ea-448d-8bb0-b22517233239","type",{"_53":59,"_54":62,"_63":64},"Peraturan Badan Pengawas Obat dan Makanan","short_name","Peraturan BPOM","subjects",[67],{"_53":68,"_54":69,"_56":-5},"10e70ff8-158d-4e9e-849e-554938c706d9","Kesehatan","location","place_of_enactment","theme","subject_matter","abstract","regulatory_relationship","Peraturan ini mencabut: 1. Peraturan Badan Pengawas Obat dan Makanan Nomor 2 Tahun 2021 tentang Pedoman Pengawasan Periklanan Obat.","scope_and_parties","","policy_content","

Peraturan Badan Pengawas Obat dan Makanan Nomor 7 Tahun 2026 tentang Promosi dan Iklan Obat diterbitkan untuk melindungi masyarakat dari informasi yang tidak objektif, tidak lengkap, dan menyesatkan dalam promosi serta iklan obat. Kebijakan ini menyesuaikan pengawasan periklanan dengan perkembangan hukum di bidang kesehatan, penyelenggaraan perizinan berusaha berbasis risiko, serta dinamika media pemasaran.

Secara substansial, peraturan ini mengatur bahwa promosi dan iklan obat hanya dapat dilakukan untuk obat yang telah memiliki izin edar. Kegiatan promosi dan iklan wajib memenuhi kriteria objektif, lengkap, dan tidak menyesatkan, serta mematuhi etika periklanan. Peraturan ini membedakan ketentuan antara obat dengan resep dan obat tanpa resep, di mana obat dengan resep hanya dapat dipromosikan kepada tenaga medis dan tenaga kesehatan melalui media ilmiah, sementara obat tanpa resep dapat diiklankan kepada masyarakat umum dengan persetujuan Kepala Badan.

Selain itu, peraturan ini menetapkan kewajiban bagi industri farmasi, pedagang besar farmasi, dan fasilitas pelayanan kefarmasian untuk menerapkan manajemen risiko dalam kegiatan promosi guna mencegah penyalahgunaan distribusi obat. Penyelenggara promosi, seperti medical representative, wajib memenuhi kualifikasi kompetensi tertentu. Peraturan ini juga melarang pemberian bonus, hadiah, atau potongan harga yang berlebihan, serta melarang promosi terselubung yang menyamarkan iklan obat melalui kegiatan penelitian atau uji klinis.

","transitional_provisions","1. Permohonan persetujuan Iklan yang telah diajukan sebelum berlakunya Peraturan Badan ini tetap diproses berdasarkan ketentuan Peraturan Badan Pengawas Obat dan Makanan Nomor 2 Tahun 2021 tentang Pedoman Pengawasan Periklanan Obat. 2. Persetujuan Iklan yang diterbitkan berdasarkan ketentuan Peraturan Badan Pengawas Obat dan Makanan Nomor 2 Tahun 2021 tentang Pedoman Pengawasan Periklanan Obat masih berlaku sepanjang tidak bertentangan dengan Peraturan Badan ini. 3. Persetujuan Iklan yang diterbitkan berdasarkan ketentuan Peraturan Badan Pengawas Obat dan Makanan Nomor 2 Tahun 2021 tentang Pedoman Pengawasan Periklanan Obat yang tidak sesuai dengan Peraturan Badan ini harus menyesuaikan dengan ketentuan dalam Peraturan Badan ini paling lambat 12 (dua belas) bulan terhitung sejak Peraturan Badan ini diundangkan.","sanctions","1. Pelanggaran terhadap ketentuan Pasal 3, Pasal 8 ayat (1), Pasal 8 ayat (2), Pasal 10 ayat (5), Pasal 11 ayat (5), Pasal 13, Pasal 17 ayat (1), Pasal 18, Pasal 32, Pasal 33, Pasal 34 ayat (1), Pasal 35 ayat (1), Pasal 36 ayat (1), Pasal 36 ayat (2), Pasal 37, Pasal 38, dan/atau Pasal 39 ayat (1) dikenakan sanksi administratif berupa peringatan, peringatan keras, penghentian sementara kegiatan, pencabutan izin edar, dan/atau pencabutan sertifikat CDOB.","revoked_by","partially_revoked_by","revokes","amended_by","amends","constitutional_review","is_verified",false,"english_excerpt","

REGULATION OF THE INDONESIAN FOOD AND DRUG AUTHORITY NUMBER 7 OF 2026 CONCERNING PROMOTION AND ADVERTISING OF MEDICINES

BY THE GRACE OF THE ONE ALMIGHTY GOD

HEAD OF THE INDONESIAN FOOD AND DRUG AUTHORITY,

Considering :

that the supervision of medicine advertising as regulated in the Regulation of the Indonesian Food and Drug Authority Number 2 of 2021 concerning Guidelines for Supervision of Medicine Advertising needs to be adjusted to legal developments in the health sector and the implementation of risk-based business licensing for the medicine and food subsector, as well as developments in media and methods for conducting marketing and/or trading activities for medicines;
that the public needs to be protected from information that is not objective, incomplete, and misleading in the promotion and advertising of medicines;
that based on the considerations as referred to in letter a and letter b, and to implement the provisions of Article 425 paragraph (2) of Government Regulation Number 28 of 2024 concerning Implementing Regulations of Law Number 17 of 2023 concerning Health, it is necessary to establish a Regulation of the Indonesian Food and Drug Authority concerning Promotion and Advertising of Medicines;

Observing :

Government Regulation Number 28 of 2024 concerning Implementing Regulations of Law Number 17 of 2023 concerning Health (State Gazette of the Republic of Indonesia of 2024 Number 135, Supplement to the State Gazette of the Republic of Indonesia Number 6952);
Presidential Regulation Number 80 of 2017 concerning the Indonesian Food and Drug Authority (State Gazette of the Republic of Indonesia of 2017 Number 180);
Regulation of the Indonesian Food and Drug Authority Number 21 of 2020 concerning the Organization and Work Procedure of the Indonesian Food and Drug Authority (State Gazette of the Republic of Indonesia of 2020 Number 1002) as amended by Regulation of the Indonesian Food and Drug Authority Number 13 of 2022 concerning Amendments to Regulation of the Indonesian Food and Drug Authority Number 21 of 2020 concerning the Organization and Work Procedure of the Indonesian Food and Drug Authority (State Gazette of the Republic of Indonesia of 2022 Number 629);
Regulation of the Indonesian Food and Drug Authority Number 19 of 2023 concerning the Organization and Work Procedure of Technical Implementation Units at the Indonesian Food and Drug Authority (State Gazette of the Republic of Indonesia of 2023 Number 611) as amended several times, most recently by Regulation of the Indonesian Food and Drug Authority Number 1 of 2026 concerning the Second Amendment to Regulation of the Indonesian Food and Drug Authority Number 19 of 2023 concerning the Organization and Work Procedure of Technical Implementation Units at the Indonesian Food and Drug Authority (State Gazette of the Republic of Indonesia of 2026 Number 61);

DECIDES:

To establish :

REGULATION OF THE INDONESIAN FOOD AND DRUG AUTHORITY CONCERNING PROMOTION AND ADVERTISING OF MEDICINES.

CHAPTER I
GENERAL PROVISIONS

","pdf_url","/proxy/pdf?id=a90a8fa7-7842-4331-ab69-0204431c3fa2","actionData","errors"]